Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/1230
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVeljanovski, Robyn-
dc.contributor.authorMcKenzie, Dean-
dc.contributor.authorD'Urso, Paul-
dc.contributor.otherBlecher, Carl-
dc.date.accessioned2017-09-08T03:05:05Z-
dc.date.available2017-09-08T03:05:05Z-
dc.date.issued2017-06-
dc.identifier.citationEpworth Research Institute Research Week 2017; Poster 50: pp 74en_US
dc.identifier.urihttp://hdl.handle.net/11434/1230-
dc.description.abstractINTRODUCTION/BACKGROUND: Autologous bone (AB) and Bone Morphogenetic Protein (BMP) can be used independently or in combination to promote bony fusion after lumbar spine surgery. However, there is ongoing uncertainty about the clinical benefit of BMP. METHOD: Clinical data was collected on 141 patients who underwent minimally invasive posterior lumbar surgery from 2008 to 2012 by a single surgeon (PD) at a single centre (Epworth HealthCare, Richmond). Patients completed questionnaires pre-surgery, and at six weeks, six months, 12 months, and 24 months post surgery. The validated outcome measures were the Oswestry Disability Index (ODI) and the visual analogue scale (VAS) for leg and back pain. CT was used to assess bony fusion by a single radiologist (CB) with a report of solid or not solid. Patients were grouped by the type of bone graft: autologous, BMP-2, and BMP-7. RESULTS: results demonstrated that solid fusion is more likely to be achieved with BMP-2 or BMP-7 rather than AB (p=0.02). However, there was no statistically significant difference between the AB and BMP groups regarding the clinical outcome. CONCLUSION: Our experience demonstrates that although patients achieved better fusion rates in the BMP groups, it did not correlate with a better clinical outcome.en_US
dc.subjectAutologous Bone Graftsen_US
dc.subjectABen_US
dc.subjectBone Morphogenetic Proteinen_US
dc.subjectBMPen_US
dc.subjectBony Fusionen_US
dc.subjectLumbar Spine Surgeryen_US
dc.subjectPosterior Lumbar Fusionen_US
dc.subjectOswestry Disability Indexen_US
dc.subjectODIen_US
dc.subjectVisual Analogue Scaleen_US
dc.subjectVASen_US
dc.subjectSolid Fusionen_US
dc.subjectClinical Institutes and Medical Audit, Epworth HealthCare, Victoria, Australiaen_US
dc.subjectResearch Development & Governance, Epworth HealthCare, Victoria, Australiaen_US
dc.subjectNeurosciences Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.titlePatient outcomes with bone morphogenetic protein (BMP) or autologous bone grafts in posterior lumbar fusion.en_US
dc.typeConference Posteren_US
dc.type.studyortrialProspective Cohort Studyen_US
dc.description.conferencenameEpworth Research Institute Research Week 2017en_US
dc.description.conferencelocationEpworth Research Institute, Victoria, Australiaen_US
dc.type.contenttypeTexten_US
Appears in Collections:Neurosciences

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.